Zentalis Pharmaceuticals, Inc. — All Filings
516 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| UPLOAD | — | 0000000000-25-003491 | Apr 1, 2025 | — |
| 10-K | 10-K | 0001725160-25-000067 | Mar 26, 2025 | Dec 31, 2024 |
| S-3 | S-3 | 0001725160-25-000069 | Mar 26, 2025 | — |
| 8-K | 8-K | 0001725160-25-000070 | Mar 26, 2025 | — |
| 8-K | 8-K | 0001628280-25-012899 | Mar 17, 2025 | Mar 15, 2025 |
| SCHEDULE 13G/A | — | 0001580642-25-001015 | Feb 14, 2025 | — |
| 4 | FORM 4 | 0001725160-25-000047 | Feb 12, 2025 | Feb 6, 2025 |
| 144 | — | 0001725160-25-000045 | Feb 11, 2025 | — |
| 4 | FORM 4 | 0001725160-25-000036 | Feb 5, 2025 | Feb 3, 2025 |
| 4 | FORM 4 | 0001725160-25-000037 | Feb 5, 2025 | Feb 3, 2025 |
| 4 | FORM 4 | 0001725160-25-000040 | Feb 5, 2025 | Feb 3, 2025 |
| 4 | FORM 4 | 0001725160-25-000041 | Feb 5, 2025 | Feb 3, 2025 |
| 4 | FORM 4 | 0001725160-25-000043 | Feb 5, 2025 | Feb 3, 2025 |
| 4 | FORM 4 | 0001725160-25-000029 | Feb 4, 2025 | Jan 31, 2025 |
| 4 | FORM 4 | 0001725160-25-000030 | Feb 4, 2025 | Jan 31, 2025 |
| 4 | FORM 4 | 0001725160-25-000028 | Feb 4, 2025 | Jan 31, 2025 |
| SCHEDULE 13G | — | 0001104659-25-009101 | Feb 4, 2025 | — |
| 144 | — | 0001725160-25-000022 | Feb 3, 2025 | — |
| 144 | — | 0001725160-25-000018 | Feb 3, 2025 | — |
| 144 | — | 0001725160-25-000020 | Feb 3, 2025 | — |
| SCHEDULE 13G/A | — | 0000932471-25-000275 | Jan 31, 2025 | — |
| SCHEDULE 13G/A | — | 0002053359-25-000002 | Jan 31, 2025 | — |
| 8-K | 8-K | 0001725160-25-000013 | Jan 29, 2025 | — |
| 8-K | 8-K | 0001725160-25-000006 | Jan 28, 2025 | Jan 22, 2025 |
| SCHEDULE 13G/A | — | 0001689655-25-000004 | Jan 22, 2025 | — |
| SCHEDULE 13G/A | — | 0001689655-25-000001 | Jan 8, 2025 | — |
| 4 | FORM 4 | 0001725160-25-000002 | Jan 3, 2025 | Jan 2, 2025 |
| 8-K/A | 8-K/A | 0001725160-24-000193 | Dec 19, 2024 | Dec 17, 2024 |
| SCHEDULE 13G | — | 0001689655-24-000020 | Dec 10, 2024 | — |
| SCHEDULE 13G/A | — | 0000315066-24-002990 | Dec 6, 2024 | — |
| 4 | FORM 4 | 0001725160-24-000190 | Dec 3, 2024 | Dec 2, 2024 |
| 4 | FORM 4 | 0001725160-24-000189 | Dec 3, 2024 | Dec 2, 2024 |
| SC 13G/A | SC 13G/A | 0001104659-24-118978 | Nov 14, 2024 | — |
| 3 | FORM 3 | 0001725160-24-000184 | Nov 13, 2024 | — |
| 3 | FORM 3 | 0001725160-24-000185 | Nov 13, 2024 | — |
| 4 | FORM 4 | 0001725160-24-000186 | Nov 13, 2024 | — |
| 8-K | 8-K | 0001725160-24-000177 | Nov 13, 2024 | Nov 12, 2024 |
| 3 | FORM 3 | 0001725160-24-000183 | Nov 13, 2024 | — |
| SC 13G/A | — | 0000932471-24-001300 | Nov 12, 2024 | — |
| 10-Q | 10-Q | 0001725160-24-000173 | Nov 12, 2024 | Sep 30, 2024 |
| SC 13G/A | SC 13G/A | 0001580642-24-006742 | Nov 6, 2024 | — |
| SC 13G/A | — | 0000932471-24-000785 | Nov 4, 2024 | — |
| 144 | — | 0001725160-24-000168 | Oct 31, 2024 | — |
| UPLOAD | — | 0000000000-24-011665 | Oct 17, 2024 | — |
| CORRESP | — | 0001725160-24-000166 | Oct 10, 2024 | — |
| SC 13G/A | — | 0000315066-24-002028 | Oct 7, 2024 | — |
| 4 | FORM 4 | 0001725160-24-000163 | Oct 4, 2024 | — |
| 8-K | 8-K | 0001725160-24-000161 | Sep 16, 2024 | — |
| UPLOAD | — | 0000000000-24-010304 | Sep 12, 2024 | — |
| 8-K | 8-K | 0001725160-24-000157 | Aug 9, 2024 | — |